<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Consolas;
panose-1:2 11 6 9 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
pre
{mso-style-priority:99;
mso-style-link:"HTML Preformatted Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Courier New";}
span.HTMLPreformattedChar
{mso-style-name:"HTML Preformatted Char";
mso-style-priority:99;
mso-style-link:"HTML Preformatted";
font-family:Consolas;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Cambria",serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">Dear all,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">FHI 360 Vietnam is currently seeking a high qualified
</span><span style="font-family:"Cambria",serif">clinical research organization (CRO) to support operations and data-collection for a Non-Inferiority Assessment to compare Dolutegravir-based (Acriptega) Antiretroviral Therapy (ART) Viral Suppression and Acceptability
to Efavirenz-based ART in Vietnam. The assessment is funded by USAID under the contract #AID-440-C-16-00001 “Sustainable HIV and Tuberculosis Response From Technical Assistance (SHIFT) Project” and cooperative agreement #7200AA19CA00002 “Meeting Targets and
Maintaining Epidemic Control (EpiC) Project”.<span style="color:black"><o:p></o:p></span></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">Interested entity should submit
</span><span style="font-family:"Cambria",serif">Complete Proposals via email to <u>
thanhha@fhi360.org</u> with a copy to <u>thuhuyen@fhi360.org</u> no later than 5:00 pm Hanoi on July 28, 2020.<o:p></o:p></span></p>
<p><span style="font-family:"Cambria",serif;color:black"><o:p> </o:p></span></p>
<p><span style="font-family:"Cambria",serif;color:black">Thanks & Best regards,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif">
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif">Ha<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><b><span style="font-size:10.0pt;color:#DE5700">Ha, Nguyen Thi Thanh</span></b><b><span style="font-size:10.0pt;color:#595959">, AD Operations</span></b><span style="font-size:10.0pt;color:#595959"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;color:#595959">7<sup>th</sup> floor, 18 Ly Thuong Kiet Street, Hanoi, Vietnam
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;color:#595959">O: +84-4-3 9348560
<u>Ext 25175</u> | F: +84-4-3 9348650 | <a href="mailto:thanhha@fhi360.org">thanhha@fhi360.org</a> | <o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="color:#6C6C6C"><img border="0" width="83" height="38" style="width:.8666in;height:.4in" id="Picture_x0020_1" src="cid:image001.jpg@01D65AB5.B00E0EA0" alt="cid:image001.jpg@01D65AB5.B00E0EA0"></span></b><span style="font-size:10.0pt;color:#595959"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;color:#1F497D"><a href="http://www.fhi360.org/" title="blocked::http://www.fhi360.org/"><span style="color:#595959">www.fhi360.org</span></a></span><span style="font-size:10.0pt;color:#595959"> | <a href="https://www.facebook.com/fhi360" title="blocked::https://www.facebook.com/fhi360"><span style="color:#595959">FHI
360 Facebook</span></a> </span><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:9.0pt;color:#262626">FHI is now FHI360. Visit us at</span><span style="font-size:9.0pt;color:#595959">
</span><span style="font-size:9.0pt;color:#1F497D"><a href="http://www.fhi360.org/">www.fhi360.org</a></span><o:p></o:p></p>
</div>
</div>
</body>
</html>